Matthew J Randell
@mjrandell.bsky.social
Postgraduate researcher at University of Warwick. Interested in the social and ethical implications of screening programmes (especially type 1 diabetes) and evidence synthesis for screening policy.
New paper sharing mothers' experiences of Down syndrome screening, including how the way their screening test result was communicated impacted them. It calls for a more neutral approach to this chance communication, and for welcoming a diversity of choices.
onlinelibrary.wiley.com/doi/10.1002/...
onlinelibrary.wiley.com/doi/10.1002/...
Down Syndrome in Maternity Care: Mothers' Experiences of Prenatal Screening
Prenatal screening for Down syndrome (DS) is offered to expectant parents receiving antenatal care in many countries, with an emphasis on providing parents with the opportunity to make informed choic...
onlinelibrary.wiley.com
August 11, 2025 at 11:25 AM
New paper sharing mothers' experiences of Down syndrome screening, including how the way their screening test result was communicated impacted them. It calls for a more neutral approach to this chance communication, and for welcoming a diversity of choices.
onlinelibrary.wiley.com/doi/10.1002/...
onlinelibrary.wiley.com/doi/10.1002/...
I forget to promote papers when they come out. Mortality data takes a long time to collect! Read this collaborative systematic review and meta analysis on the potential use of surrogate outcomes (such as late-stage cancer incidence!) in cancer screening trials.
pubmed.ncbi.nlm.nih.gov/40694037/
pubmed.ncbi.nlm.nih.gov/40694037/
LATE-STAGE OUTCOMES AS SURROGATES FOR MORTALITY IN CANCER SCREENING TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS - PubMed
Late-stage cancer incidence has been proposed as a surrogate outcome for cancer-specific mortality in future screening trials. Two previous meta-analyses with 33 and 39 trials assessed trial-level sur...
pubmed.ncbi.nlm.nih.gov
August 11, 2025 at 11:14 AM
I forget to promote papers when they come out. Mortality data takes a long time to collect! Read this collaborative systematic review and meta analysis on the potential use of surrogate outcomes (such as late-stage cancer incidence!) in cancer screening trials.
pubmed.ncbi.nlm.nih.gov/40694037/
pubmed.ncbi.nlm.nih.gov/40694037/
PGBC 2025 has landed!
4th-5th September at the Ethox centre, University of Oxford.
We welcome abstracts from postgraduates in any discipline broadly on the theme 'Disruption in Bioethics'.
Abstract deadline extended to 21st May, submit here: ime.datawareonline.co.uk/Event-Bookin...
4th-5th September at the Ethox centre, University of Oxford.
We welcome abstracts from postgraduates in any discipline broadly on the theme 'Disruption in Bioethics'.
Abstract deadline extended to 21st May, submit here: ime.datawareonline.co.uk/Event-Bookin...
May 9, 2025 at 3:15 PM
PGBC 2025 has landed!
4th-5th September at the Ethox centre, University of Oxford.
We welcome abstracts from postgraduates in any discipline broadly on the theme 'Disruption in Bioethics'.
Abstract deadline extended to 21st May, submit here: ime.datawareonline.co.uk/Event-Bookin...
4th-5th September at the Ethox centre, University of Oxford.
We welcome abstracts from postgraduates in any discipline broadly on the theme 'Disruption in Bioethics'.
Abstract deadline extended to 21st May, submit here: ime.datawareonline.co.uk/Event-Bookin...